ReviewDrug design, development and therapy2025

The Active Components of Traditional Chinese Medicines Regulate the Multi-Target Signaling Pathways of Metabolic Dysfunction-Associated Fatty Liver Disease.

Zhicong Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.